Retinal Vein Occlusion Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Retinal Vein Occlusion Market is segmented By Type Of Treatment (Anti-VEGF Therapies, Corticosteroids, Laser Therapy, Off-Label Therapy), By Type of Retinal Vein Occlusio ....
Retinal Vein Occlusion Market Size
Market Size in USD
CAGR5.7%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 5.7% |
| Market Concentration | High |
| Major Players | Roche, Regeneron Pharmaceuticals, AbbVie, Novartis, Kodiak Sciences Inc |
please let us know !
Retinal Vein Occlusion Market Analysis
The Retinal Vein Occlusion Market is estimated to be valued at USD 2.27 billion in 2024 and is expected to reach USD 5.35 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.7% from 2024 to 2031. The primary factors driving market growth are the rising geriatric population which is more susceptible to retinal diseases and increase in ophthalmic disease prevalence globally.
The Retinal Vein Occlusion market is expected to witness positive growth over the forecast period due to increasing research activities for development of novel drugs for treatment of retinal vein occlusion. Additionally, growth opportunities in emerging markets and rise in healthcare expenditure are further expected to supplement the market growth through 2031.